Abstract:Purpose: Pyroptosis is a newly discovered form of programmed pro-inflammatory cell death. The main signaling pathways include the classical scorch death pathway that depends on NLRP3 inflammatory vesicles and other activation caspase-1 and the non-classical scorch death pathway that depends on caspase-4 /5/11. The substrate of all inflammatory caspases is GSDMD; a large number of studies have confirmed that pyroptosis is associated with certain infectious diseases, atherosclerotic diseases, metabolic diseases, and aseptic inflammatory diseases of important organs. In recent years, pyroptosis has been studied partially in the ocular field. So, this article reviews the recent literature intending to help readers understand the main mechanisms of cellular scorch death and the progress of GSDMD-mediated cellular scorch death in retinal vascular inflammatory diseases. Method: A detailed review of the literature related to pyroptosis and inflammatory diseases of the retinal vasculature is presented. The following 6 electronic databases were searched: CNKI, Wanfang, VIP, PubMed, The Cochrane Library, and Embase Databases, and the search period was from the database to May 2022. The main search keywords include "Pyroptosis," " GSDMD," "Retinal Vascular Inflammatory Disease," "Diabetic retinopathy," "Retinal vasculitis." The discovery of pyroptosis, the main molecular mechanisms, key proteins, and their pathogenesis and therapeutic prospects in retinal vasculitis diseases are extensively studied and summarized. Result: The mechanisms of gasdermin D-mediated pyroptosis are elaborated and analyzed, with particular emphasis on their key role and potential in the pathogenesis and treatment of inflammatory retinal vascular lesions. Conclusion: Gasdermin D-mediated pyroptosis is a well-studied form of programmed pro-inflammatory cell death, which has a bidirectional regulatory effect on a variety of immune and inflammatory diseases. The literature reveals that pyroptosis is closely related to the pathogenesis of retinal vascular inflammatory diseases, and it may be an important therapeutic target for diabetic retinopathy and other retinal vasculitis eye diseases in the future.

[Research progress on GSDME-mediated cell pyroptosis resulting in GSDME type hearing loss]

Gain-of-function variants in GSDME cause pyroptosis and apoptosis associated with post-lingual hearing loss

Research Progresses of Molecular Mechanism of Pyroptosis and Its Related Diseases

Research Progress in Gasdermin Family Proteins and Their Association with Diseases

Gasdermin E-mediated programmed cell death: An unpaved path to tumor suppression

Insight into the structure, function and the tumor suppression effect of gasdermin E

[Research Progress on the Role of GSDME-mediated Pyroptosis in the Treatment of Lung Cancer]

GSDMD-mediated pyroptosis in retinal vascular inflammatory diseases: a review

The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles

Mini-Review: GSDME-Mediated Pyroptosis in Diabetic Nephropathy

The deafness gene GSDME: its involvement in cell apoptosis, secondary necrosis, and cancers

Gasdermin-mediated Pyroptosis Confers Anticancer Immunity

GSDMD-mediated pyroptosis: a critical mechanism of diabetic nephropathy

Molecular mechanism of GSDMD mediated glomerular endothelial cells pyroptosis: An implying in the progression of diabetic nephropathy

Transcription factor Sp1 transcriptionally enhances GSDME expression for pyroptosis

Gasdermin E: A Prospective Target for Therapy of Diseases

Pyroptosis-mediator GSDMD promotes parkinson's disease pathology via microglial activation and dopaminergic neuronal death

The Role of Cell Pyroptosis Mediated by GSDMs in Antitumor Immunity

The gasdermin family: emerging therapeutic targets in diseases

The Regulation and Modification of GSDMD Signaling in Diseases

GSDME Maintains Hematopoietic Stem Cells by Balancing Pyroptosis and Apoptosis